Your browser doesn't support javascript.
loading
Vav1 GEF activity is required for T cell mediated allograft rejection.
Haubert, Dirk; Li, Jianping; Saveliev, Alexander; Calzascia, Thomas; Sutter, Esther; Metzler, Barbara; Kaiser, Daniel; Tybulewicz, Victor L J; Weckbecker, Gisbert.
Affiliation
  • Haubert D; Novartis Institutes of BioMedical Research, Autoimmunity, Transplantation & Inflammation, 4002 Basel, Switzerland. dirk.haubert@novartis.com
Transpl Immunol ; 26(4): 212-9, 2012 Jun.
Article de En | MEDLINE | ID: mdl-22456277
ABSTRACT
The GDP exchange factor (GEF) Vav1 is a central signal transducer downstream of the T cell receptor and has been identified as a key factor for T cell activation in the context of allograft rejection. Vav1 has been shown to transduce signals both dependent and independent of its GEF function. The most promising approach to disrupt Vav1 activity by pharmacological inhibition would be to target its GEF function. However, the contribution of Vav1 GEF activity for allogeneic T cell activation has not been clarified yet. To address this question, we used knock-in mice bearing a mutated Vav1 with disrupted GEF activity but intact GEF-independent functions. T cells from these mice showed strongly reduced proliferation and activation in response to allogeneic stimulation. Furthermore, lack of Vav1 GEF activity strongly abrogated the in vivo expansion of T cells in a systemic graft-versus-host model. In a cardiac transplantation model, mice with disrupted Vav1 GEF activity show prolonged allograft survival. These findings demonstrate a strong requirement for Vav1 GEF activity for allogeneic T cell activation and graft rejection suggesting that disruption of Vav1 GEF activity alone is sufficient to induce significant immunosuppression.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T / Transplantation cardiaque / Protéines proto-oncogènes c-vav / Rejet du greffon / Maladie du greffon contre l'hôte Type d'étude: Etiology_studies / Prognostic_studies Limites: Animals Langue: En Journal: Transpl Immunol Sujet du journal: ALERGIA E IMUNOLOGIA / TRANSPLANTE Année: 2012 Type de document: Article Pays d'affiliation: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T / Transplantation cardiaque / Protéines proto-oncogènes c-vav / Rejet du greffon / Maladie du greffon contre l'hôte Type d'étude: Etiology_studies / Prognostic_studies Limites: Animals Langue: En Journal: Transpl Immunol Sujet du journal: ALERGIA E IMUNOLOGIA / TRANSPLANTE Année: 2012 Type de document: Article Pays d'affiliation: Suisse